|
|
Other links at Articles > Pharmacists |
| 3. |
Etanercept Appears Effective, Well Tolerated for Giant Cell Arteritis
|
|
|
Etanercept may potentially replace corticosteroid therapy for patients with giant cell arteritis (GCA) who are experiencing adverse effects from the corticosteroid, according to the first randomized, double-blind, placebo-controlled trial of etanercept in patients with GCA. Reuters Health Information
|
| 4. |
Enzastaurin Shows Promise as Second- or Third-Line Therapy in NSCLC
|
|
|
Enzastaurin, an oral serine/threonine kinase inhibitor, halted disease progression in some patients with metastatic non-small-cell lung cancer (NSCLC) in a single-arm, phase II study published in the March 1 issue of the Journal of Clinical Oncology. Reuters Health Information
|
| 5. |
Surfactant Protein D Reduced by Fluticasone in COPD
|
|
|
Although fluticasone with or without salmeterol does not alter systemic markers of inflammation in patients with COPD, the drugs do result in a significant reduction in the serum levels of the lung-specific surfactant protein D, Canadian researchers report. Reuters Health Information
|
|
|
